U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07944378) titled 'A Study Evaluating the Safety and Effectiveness of Lokelma in Indian Patients With Hyperkalaemia' on Nov. 03.

Brief Summary: This is a Phase IV, multicentre, open-label, non-comparative study evaluating Lokelma (sodium zirconium cyclosilicate, SZC) in approximately 100 Indian adults with mild to moderate hyperkalaemia.

Study Start Date: Aug. 08

Study Type: INTERVENTIONAL

Condition: Hyperkalemia

Intervention: DRUG: Lokelma

Sodium Zirconium Cyclosilicate SZC Lokelma 5g and 10 g

Recruitment Status: RECRUITING

Sponsor: AstraZeneca

Published by HT Digital Content Services with permission from Health Daily Digest....